CVS Health Corporation (NYSE:CVS) dropped -0.03% and closed the trade at $ 90.12. The company recorded a trading capacity of 6.41 million shares above its three months average daily volume of 4.81 million shares. During the last trade, shares reached to high price of $90.35 and touched the low price of $89.36. The stock’s 50-day moving average is noted at $95.13 and its 200-day moving average is stands at $98.29.
Additionally, the company has a PE ratio of 20.73 and has EPS of 4.35. The company has market capitalization of $96.09B.
Currently CVS Health Corporation (CVS) captured an average recommendation of “ Buy ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “17″ Analysts”. “0” rated “Sell” for the company. “4” said the company as a “Hold”. Overweight rating was given by “3” and Underweight rating was given by “0”.
Analysts are expecting that the company to achieve $112.43 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $123.00 however minimum price target advised by analysts is $104.00. The Median price target for the stock is measured at $112.00.
Presently, Analysts decided consensus EPS estimate of $1.57 for present quarter and one month ago projected EPS estimate was at $1.57. If we take a look at back 3 month ago, consensus EPS estimate was $1.55.
A current consensus EPS estimate for next quarter is at $1.79 and 3 month ago EPS forecast was $1.79. Have a look at back 1 month ago, consensus EPS forecast was seen at $1.79.
For current fiscal year, most recent EPS estimate is set at $5.86 based on Analyst consensus and three month ago consensus EPS opinions was at $5.82. During period one month ago, consensus EPS forecast was decided at $5.86.
A current consensus EPS projection for next fiscal year is observed at $6.57 and one month ago consensus EPS forecast was at $6.57. Take a look at back three month ago, consensus EPS estimate opinions was decided at $6.57 by analysts.
One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 17 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 3. 5 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Buy derived from brokerage firms, according to FactSet. 20 said a “Buy Rating” and 3 announced “Overweight Rating”. 4 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.